House Bill #7579 (2020)

AN ACT RELATING TO BUSINESSES AND PROFESSIONS - DRUG COST TRANSPARENCY

Provides drug cost transparency by requiring reports be submitted by drug manufacturers, pharmacy benefit managers and health benefit plan insurers to the director of the department of business regulation regarding drug prices and increases the prices.

View full text
View status on official RI website

Subscribe to email updates


Votes

RIBIT does not have any votes for this legislation yet.
(Vote tracking on RIBIT is still a work-in-progress, so make sure to check the official RI website, too!)